Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

ASAH1 facilitates TNBC by DUSP5 suppression-driven activation of MAP kinase pathway and represents a therapeutic vulnerability

Cell Death and Disease(2024)10.1038/s41419-024-06831-2Source: DataRank Database

ASAH1 facilitates TNBC by DUSP5 suppression-driven activation of MAP kinase pathway and represents a therapeutic vulnerability is a research paper published in Cell Death and Disease (2024). On theSindex it has a DataRank of 0.329. It has been cited 7 times, with 7 citing works in its 1-hop citation network.

N/A

0.329DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access7 citations · 7 citing works in its network

Download PDF

Cite:

Linked data & code

geo gca nct doi

Data availability

Repositories this paper deposited data in (declared in PubMed).

GEOGSE247750

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 1.24)OA: goldTopics (66)IDs (PubMed, PMC, OpenAlex)Annotations (4)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 95%Citation Network 5%

Base Score Contribution

0.312

From this paper's citation signal

Citation Network Contribution

0.0171

From 1 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 7 citers.

LncRNA NRAD1 regulates the triple-negative breast cancer transcriptome by miRNA biogenesis, localization, and predominately non-ceRNA interactions
Scientific Reports20253 citations69 referencesContributes 0.020
The SP1-SuperEnhancer-SPHK1 Axis Mediates Niraparib Resistance in TNBC
Pharmaceuticals20250 citations57 referencesContributes 0.000
MELTF-AS1 Regulates DUSP5 and Trophoblast Function via EZH2 to Inhibit Preeclampsia
Research Square20260 citations27 referencesContributes 0.000
Sphingolipid metabolism-related genes B4GALNT1 and CERS4 as prognostic biomarkers in lung adenocarcinoma
PLoS ONE20260 citations45 referencesContributes 0.000
Sphingolipids in human disease: organ-specific pathologies, chain-length-dependent effects, and translational implications
Journal of Translational Medicine20260 citations305 referencesContributes 0.000

Authors (6)

Suresh Chava ORCID,Siva Chander Chabattula ORCID,Yvonne J. K. Edwards ORCID,Kamaljeet Singh ORCID,Romi Gupta ORCID

Live enrichment

PubMed:38926346 PMC:PMC11208621 OpenAlex:https://openalex.org/W4400041703

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Grant: R01CA233481

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Grant: R03CA230815

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Grant: R03CA248913

NCI NIH HHS

Grant: P30 CA013148

National Institutes of Health

Grant: 5R03CA248913-02

A Novel Anoikis Effector that Drives Ovarian Cancer Metastasis

National Institutes of Health

Grant: 5R03CA230815-02

A NOVEL EPIGENETIC IMMUNOTHERAPY FOR OVARIAN CANCER TREATMENT

National Institutes of Health

Grant: 5R01CA233481-02

PRECISION METABOLIC THERAPY OF p53 MUTANT TRIPLE NEGATIVE BREAST CANCERS

U.S. Department of Health & Human Services | NIH | National Cancer Institute

FWCI

1.24

Citation Percentile

0.8%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1038/s41419-024-06831-2

publisherhttps://doi.org/10.1038/s41419-024-06831-2

publisherhttps://www.nature.com/articles/s41419-024-06831-2.pdf

publisherhttps://www.nature.com/articles/s41419-024-06831-2

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38926346

Fields of Study

Ubiquitin and proteasome pathwaysinterferon and immune responsesRNA modifications and cancer0301 basic medicine0303 health sciences03 medical and health sciencesHumansTriple Negative Breast NeoplasmsAcid CeramidaseDual-Specificity PhosphatasesFemaleCell Line, TumorMAP Kinase Signaling SystemCell ProliferationAnimalsGene Expression Regulation, NeoplasticMice, NudeMiceProto-Oncogene Proteins c-aktTumor Suppressor Protein p53Phosphatidylinositol 3-KinasesSignal Transduction

MeSH Terms

AnimalsFemaleHumansMice, NudeSignal TransductionGene Expression Regulation, NeoplasticTumor Suppressor Protein p53Phosphatidylinositol 3-KinasesMAP Kinase Signaling SystemCell Line, TumorCell ProliferationProto-Oncogene Proteins c-aktMiceDual-Specificity PhosphatasesAcid CeramidaseTriple Negative Breast Neoplasms

Keywords

Cell biologyKinaseVulnerability (computing)Signal transductionBiologyCancer researchChemistryComputational biologyComputer scienceComputer securityQH573-671Acid CeramidaseMAP Kinase Signaling SystemMice, NudeTriple Negative Breast NeoplasmsArticleGene Expression Regulation, NeoplasticMicePhosphatidylinositol 3-KinasesCell Line, TumorHumansDual-Specificity PhosphatasesAnimalsFemaleTumor Suppressor Protein p53CytologyProto-Oncogene Proteins c-aktCell Proliferation

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being